Skilled Nursing Facility

Immunocompromised Medicare beneficiaries eligible to receive additional COVID-19 vaccine shot

The Food and Drug Administration recently authorized an additional dose of COVID-19 vaccine for immunocompromised individuals. CMS, in response, is assuring that eligible Medicare beneficiaries can receive it with no cost sharing.

CMS will share more information and guidance in the coming days about billing and coding for the additional dose of the COVID-19 vaccine for immunocompromised patients.

For additional information: